Suzanne E. Brage

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A human pan-disease blood atlas of the circulating proteome.

A human pan-disease blood atlas of the circulating proteome.

Journal: Science (New York, N.Y.)

Published: October 09, 2025

Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.

Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.

Journal: Pigment cell & melanoma research

Published: May 30, 2025

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Journal: Cancers

Published: December 15, 2021

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma.

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma.

Journal: PloS one

Published: August 01, 2018

Immune gene expression and response to chemotherapy in advanced breast cancer.

Immune gene expression and response to chemotherapy in advanced breast cancer.

Journal: British journal of cancer

Published: July 24, 2017

ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.

ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 21, 2017

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.

Journal: Cell reports

Published: June 10, 2015

Metabolic markers and HSP60 in chemonaive serous solid ovarian cancer versus ascites.

Metabolic markers and HSP60 in chemonaive serous solid ovarian cancer versus ascites.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 05, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026